Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses
BEGIN
1 other identifier
interventional
13
1 country
1
Brief Summary
The aim of this study is to determine whether eating breakfast or having no breakfast has subsequent beneficial health effects, specifically in relation to glycemic response throughout the day and postprandial insulin and non-esterified fatty acids (NEFA) responses 6 hours after breakfast/lunch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2017
CompletedFirst Submitted
Initial submission to the registry
August 9, 2017
CompletedFirst Posted
Study publicly available on registry
August 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2019
CompletedMay 13, 2019
May 1, 2019
1.7 years
August 9, 2017
May 10, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Glycemic response
Using continuous glucose monitoring system
1.5 days
Insulin response
Postprandial after treatment
6 hours
Non-esterified fatty acids (NEFA) response
Postprandial after treatment
6 hours
Study Arms (2)
Breakfast
EXPERIMENTALSubject given standardized breakfast (glutinous rice) to test blood glucose response
No breakfast
EXPERIMENTALSubject not given breakfast to test blood glucose response
Interventions
Eligibility Criteria
You may qualify if:
- Chinese males
- BMI above 23.0 kg/m2
- Age between 40-65 years
- Normal blood pressure (\<140/90 mmHg)
- Fasting blood glucose of ≥5.6 mmol/L
- Self-reported regular breakfast consumers
You may not qualify if:
- Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency
- major chronic disease such as heart disease, cancer or diabetes mellitus
- taking insulin or drugs known to affect glucose metabolism
- Intentionally restrict food intake
- major medical or surgical event requiring hospitalization within the preceding 3 months
- Have taken antibiotics for 3 months before the study period
- Smoking
- Overnight shift workers
- Any known food allergy (eg. anaphylaxis to peanuts)
- Having active Tuberculosis (TB) or currently receiving treatment for TB
- Any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- Being a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
- Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- JeyaKumar Henrylead
- General Millscollaborator
Study Sites (1)
Clinical Nutrition Research Centre
Singapore, 117599, Singapore
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 9, 2017
First Posted
August 22, 2017
Study Start
July 25, 2017
Primary Completion
March 28, 2019
Study Completion
March 28, 2019
Last Updated
May 13, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share